Alvin Wong, the first batch of international students after the reform and opening-up, received a doctorate in molecular biology from the University of Wisconsin. He joined the Chinese University of Hong Kong School of Medicine from 1992 and was promoted to professor of biochemistry from 1999. [ 1]
At present, he is the founder/president of Gene Harbor (Hong Kong) Biotechnology Co., Ltd., an adjunct professor at the Chinese University of Hong Kong, and a tutor of Hong Kong X Entrepreneurship Platform. ? [ 1]?
He has been engaged in molecular biology, biotechnology research and development and industrial production in universities, government departments and biotechnology companies in China, the United States, Australia and Hongkong for more than 40 years. He is one of the inventors of more than 80 patents and the first professor of innovation and technology in Hong Kong? [1], member of biotechnology group of research project of Innovation and Technology Fund of Hong Kong Special Administrative Region.
Major in biochemistry, molecular biology, enzyme engineering and biosynthesis. [1] The research team includes more than 30 scientists in the fields of genetics, protein engineering, biochemistry, industrial fermentation and information engineering. Most of them have doctoral or master's degrees in related fields. [3]
In Alvin Wong, enzymatic method has not been widely used in manufacturing industry, which is mainly due to the high preparation cost of enzymes and coenzymes and the low efficiency of enzyme reactors. Gene port has been devoted to the research of new enzymes for many years, and has developed original patented technologies with independent intellectual property rights, and developed more than ten new technologies for producing medicines and foods. ? [4]?
One example is the anti-aging product nicotinamide adenine mononuclease acid. Another example is the natural antioxidant "glutathione".